Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiving tonsillectomy
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
174
sugammadex as reversal agent
neostigmine as a reversal agent
Seoul national university hospital
Seoul, South Korea
Perioperative respiratory adverse events
the incidence of overall perioperative respiratory adverse events; oxygen desaturation \< 95%, airway obstruction, laryngospasm, bronchospasm, severe coughing, or postoperative stridor
Time frame: from induction of anesthesia to end of operation, about 3 hours
bradycardia
administration of IV atropine, glycopyrrolate, epinephrine, ephedrine
Time frame: from induction of anesthesia to end of operation, about 3 hours
Cardiac arrest
documented chest compressions/defibrillation/cardioversion
Time frame: from induction of anesthesia to end of operation, about 3 hours
Anaphylaxis
administration of epinephrine, methylprednisolone, diphenhydramine, documented diagnosis of anaphylactic/ anaphylatoid reaction
Time frame: from induction of anesthesia to end of operation, about 3 hours
Allergic reaction
redness, urticaria, wheeze
Time frame: from induction of anesthesia to end of operation, about 3 hours
Bronchospasm
administration of albuterol, epinephrine
Time frame: from induction of anesthesia to end of operation, about 3 hours
Nausea and vomiting
Time frame: from induction of anesthesia to end of operation, about 3 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.